Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-01

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the analgesic properties of ultrasound guided supraclavicular block using ropivacaine 0.5% in arteriovenous fistula creation when used in combination with intravenous administered dexamethasone at 4mg and 8 mg as an adjuvant

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intravenous Dexamethasone for Ropivacaine Axillary Block

NCT02862327

Postoperative Pain Anesthesia Forearm Injuries

COMPLETED PHASE3

Peri-neural Dexmedetomidine Versus Dexamethasone for Supraaclavicular Block Adjuvant to Bupivacaine Supraclavicular Brachial Plexus Block

NCT04694105

Brachial Plexus Block

COMPLETED NA

Intravenous and Perineural Dexamethasone for Ultrasound-Guided Axillary Blocks

NCT02629835

Brachial Plexus Block Duration

COMPLETED PHASE2/PHASE3

A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting

NCT02331030

Arteriovenous Fistula Arteriovenous Graft Kidney Failure, Chronic +1 more

COMPLETED NA

Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block

NCT02787018

Brachial Plexus Block

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GROUP DF

supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous dexamethasone 4mg

Group Type ACTIVE_COMPARATOR

supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone

Intervention Type DRUG

Comparing the onset of sensory, motor block, duration of motor block and analgesic duration

GROUP DE

supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous dexamethasone 8mg

Group Type ACTIVE_COMPARATOR

supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone

Intervention Type DRUG

Comparing the onset of sensory, motor block, duration of motor block and analgesic duration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone

Comparing the onset of sensory, motor block, duration of motor block and analgesic duration

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adult, age 18 to 65 years End stage renal disease patients for AV fistula creation

Exclusion Criteria

Not suitable candidate as determined by the primary team Refusal for brachial plexus block History of allergy to dexamethasone or local anesthesia Pregnancy History of previous brachial plexus injury Coagulopathy Local skin site infection Known neuropathy involving the arm undergoing surgery Patients with glucose reading more then 12mmol/

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No